GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Question] Australia — has anyone got a straight answer on dual agonist — 40 comments in the full submission. View in context.
1.6k
c/tirzepatide·submitted 4 months ago by u/cato_girard

[Question] Australia — has anyone got a straight answer on dual agonist

Questionbranch of 9 comments

I have had 2 orders now and I keep a table, so here is the honest summary rather than a vibe. Material has been consistent. Communication has not. Shipping has varied by about 14 days on nominally the same lane, which matters more in summer than in February. The independent number came back 97.9% against a claimed…

Read the full submission and all 40 comments →

This branch

9 comments, started 4 months ago
u/laila_wikstrom295 points·4 months ago

I love that this community will spend 40 comments on a detail. That pedantry is why the numbers here matter.

replysharereportpermalink
u/cato_girardOP214 points·4 months ago

SURMOUNT data is messier than STEP data but the weight loss is there

replysharereportpermalink
u/slow_logbook_ftw169 points·4 months ago

the nausea from tirz is different, not necessarily worse

replysharereportpermalink
u/hair_shed_hannah57 points·4 months ago

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

replysharereportpermalink
u/cato_girardOP133 points·4 months ago

dual agonism is dual agonist, do not generalise from semaglutide

replysharereportpermalink
u/ahmed_fonseca225 points·4 months ago

Yeah, dual agonism does produce a different appetite profile than GLP-1 alone.

replysharereportpermalink
u/tarek_kirchner64 points·4 months ago

Cosigning. The GIP contribution is real and the side effects are not simply scaled versions.

replysharereportpermalink
u/georgi_chowdhury124 points·4 months ago

the 15mg is the top of the pen, not the required dose

replysharereportpermalink
u/laila_wikstrom-5 points·4 months ago

dual agonism is Mounjaro, do not generalise from semaglutide

replysharereportpermalink

← back to the whole thread

About c/tirzepatide

Tirzepatide-specific discussion: the dual-agonist pharmacology, the 2.5 → 15mg ladder, the appetite profile people describe as different from semaglutide, and the SURMOUNT/SURPASS trial programme. Comparisons with semaglutide are welcome as long as they are specific about dose equivalence being unknown.

187kmembers
130submissions
Aug 2023created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.com
Sponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
c/tirzepatide rules
  1. "Tirz is better than sema" needs a comparator dose or it is a vibe, not a claim.
  2. Vial-splitting and self-compounding discussion stays in c/reconstitution.
  3. No pen-cracking tutorials. Discussing that people do it is fine; instructions are not.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.